Jian Min Fang
Chief Executive Officer en REMEGEN CO., LTD. .
Fortuna: 84 M $ al 31/03/2024
Cargos activos de Jian Min Fang
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| REMEGEN CO., LTD. | Director/Board Member | 04/07/2008 | - |
| Chief Executive Officer | 04/07/2008 | - | |
| Chief Tech/Sci/R&D Officer | 04/07/2008 | - | |
| Founder | 04/07/2008 | - | |
MabPlex International Co., Ltd.
 MabPlex International Co., Ltd. Pharmaceuticals: MajorHealth Technology MabPlex International Co., Ltd. engages in the provision of contract development and manufacturing organization (CDMO) services in the biopharmaceutical field. It provides CDMO services for monoclonal antibodies, double antibodies, polyclonal antibodies, fusion proteins, antibody-drug conjugates, recombinant vaccines, recombinant proteins, and other biological drugs; and cell culture medium. The company was founded by Jan Min Fang on June 25, 2013 and is headquartered in Yantai, China. | Founder | 25/06/2013 | - |
| Chairman | 25/06/2013 | - | |
| Chief Executive Officer | 25/06/2013 | 01/03/2020 | |
| Remegen Medical Research Shanghai Co. Ltd. | Director/Board Member | - | - |
| Remegen Biosciences, Inc. | Director/Board Member | - | - |
| Remegen Hong Kong Ltd. | Director/Board Member | - | - |
| Chinese Pharmaceutical Association | Director/Board Member | - | - |
| China Medicinal Biotech Association | Corporate Officer/Principal | - | - |
Historial de carrera de Jian Min Fang
Formación de Jian Min Fang.
| Dalhousie University | Doctorate Degree |
Estadísticas
Internacional
| China | 6 |
| Canadá | 2 |
| Estados Unidos | 2 |
Operativa
| Director/Board Member | 5 |
| Chief Executive Officer | 2 |
| Founder | 2 |
Sectorial
| Health Technology | 3 |
| Consumer Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| REMEGEN CO., LTD. | Health Technology |
| Empresas privadas | 6 |
|---|---|
| Chinese Pharmaceutical Association | |
| China Medicinal Biotech Association | |
MabPlex International Co., Ltd.
MabPlex International Co., Ltd. Pharmaceuticals: MajorHealth Technology MabPlex International Co., Ltd. engages in the provision of contract development and manufacturing organization (CDMO) services in the biopharmaceutical field. It provides CDMO services for monoclonal antibodies, double antibodies, polyclonal antibodies, fusion proteins, antibody-drug conjugates, recombinant vaccines, recombinant proteins, and other biological drugs; and cell culture medium. The company was founded by Jan Min Fang on June 25, 2013 and is headquartered in Yantai, China. | Health Technology |
| Remegen Medical Research Shanghai Co. Ltd. | |
| Remegen Biosciences, Inc. | |
| Remegen Hong Kong Ltd. |
- Bolsa de valores
- Insiders
- Jian Min Fang
- Experiencia
